The company also reported GAAP net income of $8.5 million for the second quarter of 2012, compared to GAAP net income of $0.7 million for the second quarter of 2011. However, the company's United States spine business reported a 4 percent decrease over the same period last year, reaching only $45.7 million in the second quarter.
In the United States, the orthopedics business grew 22 percent to $80.7 million but dropped 2 percent internationally. The company's U.S. neurosurgery market grew only 2 percent while the international market saw a 5 percent decrease. Worldwide, the neurosurgery market decreased by 1 percent to $67.7 million.
"We had a good quarter across all our businesses and are making solid progress against our priorities," said Peter Arduini, Integra LifeSciences president and CEO. "Revenues, gross margin and earnings per share all increased both year-over-year and sequentially."
Integra LifeSciences Reports $210.2M Revenue for 2Q, 9% Increase FeaturedWritten by Jaimie Oh | July 27, 2012
Integra LifeSciences reported total revenues for the second quarter were $210.2 million, reflecting a 9 percent increase compared to the same period last year.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.